Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial

J Hepatol. 2001 Mar;34(3):486-8. doi: 10.1016/s0168-8278(01)00018-6.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Drug Combinations
  • Drug Resistance
  • Female
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Interferons / therapeutic use*
  • Male
  • Middle Aged
  • Retreatment
  • Serum Albumin / therapeutic use*
  • Vidarabine Phosphate / therapeutic use*

Substances

  • Drug Combinations
  • Serum Albumin
  • lactosaminated serum albumin
  • Vidarabine Phosphate
  • Interferons